U.S. Markets closed

Emergent BioSolutions Inc. (EBS)


NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
29.52-0.22 (-0.74%)
At close: 4:02PM EDT

29.52 0.00 (0.00%)
After hours: 4:19PM EDT

People also watch
ACORMNTAALNYCBMOSIR
Interactive chart
Previous Close29.74
Open29.62
Bid0.00 x
Ask0.00 x
Day's Range29.31 - 29.91
52 Week Range24.47 - 44.38
Volume345,440
Avg. Volume315,595
Market Cap1.21B
Beta1.48
PE Ratio (TTM)23.47
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Capital Cube6 hours ago

    ETFs with exposure to Emergent BioSolutions, Inc. : May 22, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Emergent BioSolutions, Inc. Here are 5 ETFs with the largest exposure to EBS-US. Comparing the performance and risk of Emergent BioSolutions, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • Emergent BioSolutions, Inc. :EBS-US: Earnings Analysis: Q1, 2017 By the Numbers : May 19, 2017
    Capital Cube3 days ago

    Emergent BioSolutions, Inc. :EBS-US: Earnings Analysis: Q1, 2017 By the Numbers : May 19, 2017

    Categories: Yahoo FinanceGet free summary analysis Emergent BioSolutions, Inc. reports financial results for the quarter ended March 31, 2017. We analyze the earnings along side the following peers of Emergent BioSolutions, Inc. – SIGA Technologies Inc, Merck & Co., Inc., XOMA Corporation, Chimerix, Inc., Celgene Corporation, Celldex Therapeutics, Inc., GlaxoSmithKline plc Sponsored ADR, Pfizer Inc. and GenVec, ... Read more (Read more...)

  • Thomson Reuters StreetEvents13 days ago

    Edited Transcript of EBS earnings conference call or presentation 4-May-17 9:00pm GMT

    Q1 2017 Emergent BioSolutions Inc Earnings Call